Anhui Pioneer Pharmaceutical Co., Ltd.
-
Founded in:
2004-01-14 -
Country:
China -
Address:
No. 35, Hongfeng Road, Hefei High-tech Industrial Development Zone -
Tax NO.:
91340100758501263P -
Registered Funds:
20 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Azithromycin |
Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.
More
Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains. |
83905-01-5 | 39 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefoperazone |
It achieves bactericidal effect by inhibiting biosynthesis of sensitive bacterial cell walls. It has obvious synergistic effect when used in combination with sulbactam and is effective against all bacteria sensitive to cefoperazone.
More
It achieves bactericidal effect by inhibiting biosynthesis of sensitive bacterial cell walls. It has obvious synergistic effect when used in combination with sulbactam and is effective against all bacteria sensitive to cefoperazone. |
0.5g | 62893-19-0 | 2 |
| Sulbactam pivoxil |
It has an irreversible inhibitory effect on most important β-lactamases produced by β-lactam antibiotic-resistant strains, and can protect β-lactam antibiotics from hydrolysis and destruction by β-lactamases of resistant bacteria. It has a significant synergistic effect when used in combination with cefoperazone, and can enhance the effect on certain sensitive strains.
More
It has an irreversible inhibitory effect on most important β-lactamases produced by β-lactam antibiotic-resistant strains, and can protect β-lactam antibiotics from hydrolysis and destruction by β-lactamases of resistant bacteria. It has a significant synergistic effect when used in combination with cefoperazone, and can enhance the effect on certain sensitive strains. |
0.5g | 69388-79-0 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefoperazone sodium |
It is a third-generation cephalosporin that achieves bactericidal effect by inhibiting the biosynthesis of sensitive bacterial cell walls. When used in combination with sulbactam, it has a significant synergistic effect and enhances the effect on drug-resistant strains.
More
It is a third-generation cephalosporin that achieves bactericidal effect by inhibiting the biosynthesis of sensitive bacterial cell walls. When used in combination with sulbactam, it has a significant synergistic effect and enhances the effect on drug-resistant strains. |
0.5g | 62893-20-3 | 23 |
| Sulbactam sodium |
It has an irreversible inhibitory effect on most important β-lactamases produced by β-lactam antibiotic-resistant strains, protects β-lactam antibiotics from hydrolysis and enhances the antibacterial effect. It has a significant synergistic effect when used in combination with cefoperazone.
More
It has an irreversible inhibitory effect on most important β-lactamases produced by β-lactam antibiotic-resistant strains, protects β-lactam antibiotics from hydrolysis and enhances the antibacterial effect. It has a significant synergistic effect when used in combination with cefoperazone. |
0.5g | 69388-84-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fenofibrate |
By inhibiting the production of very low-density lipoprotein and triglyceride and increasing their catabolism, it reduces blood low-density lipoprotein, cholesterol and triglyceride; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. It also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic.
More
By inhibiting the production of very low-density lipoprotein and triglyceride and increasing their catabolism, it reduces blood low-density lipoprotein, cholesterol and triglyceride; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. It also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic. |
49562-28-9 | 63 |